Skip to main content
. 2021 Sep 12;2021(9):CD011612. doi: 10.1002/14651858.CD011612.pub3

NCT04019704.

Methods Randomised, double‐blind, placebo‐controlled study
Participants 327 participants with depression
Interventions Drug: AXS‐05
Drug: placebo
Outcomes Adverse events
MADRS
Notes Trial completed December 2019, no results available yet.